Accéder au contenu
MilliporeSigma
Toutes les photos(1)

Documents

Y0001287

Heparin calcium for NMR identification

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

Heparin calcium salt

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Numéro CAS:
37270-89-6
Code UNSPSC :
41116107
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

heparin

Fabricant/nom de marque

EDQM

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Heparin calcium for NMR identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

H0185000

Heparin Low-Molecular-Mass for assay BRP, European Pharmacopoeia (EP) Reference Standard

H0200000

Heparin sodium, BRP, European Pharmacopoeia (EP) Reference Standard

1304016

Heparin sodium for assays, United States Pharmacopeia (USP) Reference Standard

1304038

Heparin sodium identification, United States Pharmacopeia (USP) Reference Standard

Y0001321

Dermatan sulfate and oversulfated chondroitin sulfate, European Pharmacopoeia (EP) Reference Standard

Y0001282

Heparin for physico-chemical analysis, European Pharmacopoeia (EP) Reference Standard

Y0001283

Heparin sodium for NMR identification, European Pharmacopoeia (EP) Reference Standard

1133580

Oversulfated Chondroitin Sulfate, United States Pharmacopeia (USP) Reference Standard

1304049

Heparin Sodium System Suitability, United States Pharmacopeia (USP) Reference Standard

1304050

Heparin Sodium with Oversulfated Chondroitin Sulfate, United States Pharmacopeia (USP) Reference Standard

1304130

Low Molecular Weight Heparin for Boron Analysis, United States Pharmacopeia (USP) Reference Standard

1304107

Heparin Sodium Molecular Weight Calibrant, United States Pharmacopeia (USP) Reference Standard

1304118

Low Molecular Weight Heparin for Bioassays, United States Pharmacopeia (USP) Reference Standard

1448854

Low Molecular Weight Heparin Molecular Weight Calibrant, United States Pharmacopeia (USP) Reference Standard

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Choose from one of the most recent versions:

Certificats d'analyse (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Depression improvement with calcium heparin.
Salvador Sarro Maluquer et al.
General hospital psychiatry, 24(6), 450-451 (2002-12-20)
L Bonnecarrère et al.
Journal des maladies vasculaires, 34(5), 366-371 (2009-09-29)
Subcutis calcinosis, characterized by abnormal calcium deposition in the skin, is a rare side effect of calcium containing heparins. Two patients with renal failure presented skin lesions after receiving a calcium-containing heparin treatment. The first patient exhibited erythematous nodules on
Eosinophilic panniculitis and hypereosinophilia caused by hypersensitivity to calcium heparin.
Masahito Yasuda et al.
European journal of dermatology : EJD, 20(3), 401-402 (2010-04-20)
Claudio Zanon et al.
Tumori, 91(6), 477-480 (2006-02-07)
The evaluation of low-molecular-weight heparin use to prevent arterial and venous thrombosis in patients with indwelling arterial Port-a-Cath implants. From 1996 to March 2003 we placed 370 indwelling hepatic arterial catheters with a minimally invasive approach. The left distal subclavian
M R Caballero et al.
Allergologia et immunopathologia, 31(6), 324-328 (2003-12-13)
Few descriptions of allergic reactions to heparin have been published, because these reactions are not well known, their prevalence is low and they are difficult to diagnose due to the lack of an in vitro test until now. We propose
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique